Rachael Keating
Overview
Explore the profile of Rachael Keating including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1069
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pellicci D, Hammond K, Coquet J, Kyparissoudis K, Brooks A, Kedzierska K, et al.
J Immunol
. 2024 Mar;
212(10):1603.
PMID: 38536025
No abstract available.
2.
Keating R, Curry S, Hussey J
Support Care Cancer
. 2023 Jun;
31(7):395.
PMID: 37318588
Purpose: We assessed cardiorespiratory fitness and health-related quality of life (HRQoL) in survivors of childhood central nervous system (CNS) tumours. Methods: Participants were recruited from the National Children's Cancer Service...
3.
Labombarde J, Pillai M, Wehenkel M, Lin C, Keating R, Brown S, et al.
Cell Rep
. 2022 Mar;
38(10):110482.
PMID: 35263574
Infection and vaccination repeatedly expose individuals to antigens that are conserved between influenza virus subtypes. Nevertheless, antibodies recognizing variable influenza epitopes greatly outnumber antibodies reactive against conserved epitopes. Elucidating factors...
4.
Keating R, Johnson J, Brice D, Labombarde J, Dent A, McGargill M
mBio
. 2020 Nov;
11(6).
PMID: 33144374
Enhancing the generation of broadly reactive antibodies against influenza A virus (IAV) is a pertinent goal toward developing a universal IAV vaccine. While antibodies that bind conserved IAV epitopes have...
5.
Keating R, Morris M, Yue W, Reynolds C, Harris T, Brown S, et al.
Immunol Cell Biol
. 2018 Jul;
96(10):1104-1119.
PMID: 29972699
Current influenza A virus (IAV) vaccines stimulate antibody responses that are directed against variable regions of the virus, and are therefore ineffective against divergent strains. As CD8 T cells target...
6.
Keating R, McGargill M
Front Immunol
. 2016 Jun;
7:180.
PMID: 27242787
Immunity to pathogens exists as a fine balance between promoting activation and expansion of effector cells, while simultaneously limiting normal and aberrant responses. These seemingly opposing functions are kept in...
7.
Keating R, Hertz T, Wehenkel M, Harris T, Edwards B, McClaren J, et al.
Nat Immunol
. 2013 Oct;
14(12):1266-76.
PMID: 24141387
Highly pathogenic avian influenza viruses pose a continuing global threat. Current vaccines will not protect against newly evolved pandemic viruses. The creation of 'universal' vaccines has been unsuccessful because the...
8.
Boltz D, Douangngeun B, Phommachanh P, Sinthasak S, Mondry R, Obert C, et al.
J Gen Virol
. 2009 Dec;
91(Pt 4):949-59.
PMID: 20016036
Pandemic influenza viruses can emerge through continuous evolution and the acquisition of specific mutations or through reassortment. This study assessed the pandemic potential of H5N1 viruses isolated from poultry outbreaks...
9.
Rutigliano J, Morris M, Yue W, Keating R, Webby R, Thomas P, et al.
J Virol
. 2009 Nov;
84(2):1047-56.
PMID: 19889782
Human infections with highly pathogenic H5N1 avian influenza A viruses in the last decade have legitimized fears of a long-predicted pandemic. We thus investigated the response to secondary infections with...
10.
Boltz D, Douangngeun B, Sinthasak S, Phommachanh P, Midouangchanh P, Walker D, et al.
Arch Virol
. 2009 May;
154(6):939-44.
PMID: 19458904
Despite the extensive use of poultry vaccines to control the spread of H5N1 influenza in poultry, H5N1 outbreaks continue to occur in domestic birds. Our objective was to determine the...